Global X China Biotech Innovation ETF
Not enough financial coverage to compute a composite score for CHB. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts ("GDRs") based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China’s biotechnology industry. It is non-diversified.
- IPO
- 2020
- HQ
- US
Price Chart
Valuation
- Market Cap
- $1.39M
- Div Yield
- 0.59%
Performance & Tape
- 52W High
- $9.76
- 52W Low
- $6.63
- 50D MA
- $7.26
- 200D MA
- $7.66
- Beta
- 0.66
- Avg Volume
- 712
Get TickerSpark's AI analysis on CHB
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 6, 09 | LYNCH GEORGE M | other | 7,000 |
| May 6, 09 | MADDEN THOMAS A | other | 8,050 |
| May 6, 09 | ANESTIS ROBERT W | other | 7,000 |
| Mar 6, 09 | SCHOLTEN ROGER K | other | 85,000 |
| Mar 6, 09 | GRIFFITHS WILLIAM C | other | 200,000 |
| Mar 6, 09 | MADDEN THOMAS A | buy | 50,000 |
| Feb 24, 09 | ANESTIS ROBERT W | buy | 37,000 |
| Feb 24, 09 | ANESTIS ROBERT W | buy | 35,000 |
| Feb 20, 09 | GRIFFITHS WILLIAM C | other | 30,228 |
| Feb 18, 09 | GRIFFITHS WILLIAM C | other | 15,000 |
Our CHB Coverage
We haven't published any research on CHB yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CHB Report →